Radiation Oncologist: Abhishek Solanki, MD | Loyola Medicine

Abhishek Solanki, MD

Abhishek Solanki, MD

Radiation Oncology

Associate Professor
Quality Medical Director, Radiation Oncology

Languages Spoken

English, Gujarati
Patient Ratings
4.9 / 5 (60 Ratings)

Clinical Expertise

  • Acoustic Tumors
  • Bladder Cancer
  • Brain Tumor
  • HDR Prostate Brachytherapy
  • Kidney Cancer
  • Meningioma
  • Pituitary Tumor
  • Prostate Brachytherapy
  • Prostate Cancer
  • Prostate IMRT
  • Radiosurgery
  • Spinal Tumor
  • Spine Radiosurgery
  • Testicular Cancer

About Dr. Solanki

Exercise, Drawing & Painting, Family and Friends, Movies, Travel, Chicago Bulls

Medical Education

Medical School
University of Chicago
University of Chicago Medical Center - Radiation Oncology

Board Certification

American Board of Radiology Subspecialty Radiation Oncology


  • Computed tomography versus magnetic resonance imaging in high-dose-rate prostate brachytherapy planning: The impact on patient-reported health-related quality of life. Harris, AA; Wu, M; Deirmenjian, JM; Shea, SM; Kang, H; Patel, R; Fielder, D; Mysz, ML; Harkenrider, MM; Solanki, AA, Brachytherapy
  • F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE. Solanki, AA; Savir-Baruch, B; Liauw, SL; Michalski, J; Tward, JD; Vapiwala, N; Teoh, EJ, Practical radiation oncology
  • Patient and physician reported toxicity with two-fraction definitive high-dose-rate prostate brachytherapy: the impact of implant interval. Harris, AA; Korpics, M; Sherwani, Z; Farooq, A; Baldea, KG; Flanigan, R; Harkenrider, MM; Solanki, AA, Journal of contemporary brachytherapy
View All ResearchShow Less
  • Safety practices and opportunities for improvement in brachytherapy: A patient safety practices survey of the American Brachytherapy Society membership. Sanders, JC; Showalter, TN; Ouhib, Z; Thomadsen, BR; Jacob, D; Agarwal, M; Cohen, GN; Giles, M; Palaniswammy, G; Solanki, AA; Taunk, NK, Brachytherapy
  • Three discipline collaborative radiation therapy (3DCRT) special debate: Peer review in radiation oncology is more effective today than 20 years ago. Ahmad, A; Santanam, L; Solanki, AA; Padilla, L; Vlashi, E; Guerrieri, P; Dominello, MM; Burmeister, J; Joiner, MC, Journal of Applied Clinical Medical Physics
  • EDITORIAL COMMENT. Solanki, AA; Efstathiou, JA, Urology
  • Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer. Savir-Baruch, B; Lovrec, P; Solanki, AA; Adams, WH; Yonover, PM; Gupta, G; Schuster, DM, AJR. American journal of roentgenology
  • NRG brain tumor specialists consensus guidelines for glioblastoma contouring. Kruser, TJ; Bosch, WR; Badiyan, SN; Bovi, JA; Ghia, AJ; Kim, MM; Solanki, AA; Sachdev, S; Tsien, C; Wang, TJC; Mehta, MP; McMullen, KP, Journal of neuro-oncology
  • The Impact of Transitioning to Prospective Contouring and Planning Rounds as Peer Review. Surucu, M; Bajaj, A; Roeske, JC; Block, AM; Price, J; Small, W; Solanki, AA, Advances in radiation oncology
  • The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer. Solanki, AA; Liauw, SL, Translational andrology and urology
  • Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies. Solanki, AA; Bossi, A; Efstathiou, JA; Lock, D; Mondini, M; Ramapriyan, R; Welsh, J; Kang, J, EUROPEAN UROLOGY ONCOLOGY
  • Cranial Base Meningiomas Prabhu, V. C.; Melian, E.; Germanwala, A. V.; Solanki, A. A.; Borys, E.; Barton, K.; Anderson, D. E., World neurosurgery
  • Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy. Silva, SR; Gliniewicz, A; Martin, B; Prabhu, VC; Germanwala, AV; Melian, E; Jones, GA; Solanki, AA, World neurosurgery
  • Optimizing the Role of Surgery and Radiation Therapy in Urethral Cancer Based on Histology and Disease Extent. Son, CH; Liauw, SL; Hasan, Y; Solanki, AA, International journal of radiation oncology, biology, physics
  • Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017. Okunieff, P; Casey-Sawicki, K; Lockney, NA; Hoppe, BS; Enderling, H; Pinnix, C; Welsh, J; Krishnan, S; Yothers, G; Brown, M; Knox, S; Bristow, R; Spellman, P; Mitin, T; Nabavizadeh, N; Jaboin, J; Manning, HC; Feng, F; Galbraith, S; Solanki, AA; Harkenrider, MM; Tuli, R; Decker, RH; Finkelstein, SE; Hsu, CC; Ha, CS; Jagsi, R; Shumway, D; Daly, M; Wang, TJC; Fitzgerald, TJ; Laurie, F; Marshall, DT; Raben, D; Constine, L; Thomas, CR; Kachnic, LA, Clinical cancer research : an official journal of the American Association for Cancer Research
  • The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer Bajaj, A.; Martin, B.; Bhasin, R.; Hentz, C.; Block, A. M.; Harkenrider, M. M.; Solanki, A. A., International journal of radiation oncology, biology, physics
  • Transitioning From a Low-Dose-Rate to a High-Dose-Rate Prostate Brachytherapy Program: Comparing Initial Dosimetry and Improving Workflow Efficiency Through Targeted Interventions. Solanki, AA; Mysz, ML; Patel, R; Surucu, M; Kang, H; Plypoo, A; Bajaj, A; Korpics, M; Martin, B; Hentz, C; Gupta, G; Farooq, A; Baldea, KG; Pawlowski, J; Roeske, J; Flanigan, R; Small, W; Harkenrider, MM, Advances in radiation oncology
  • Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer Solanki, A. A.; Martin, B.; Korpics, M.; Small, C.; Harkenrider, M. M.; Mitin, T., Clinical oncology (Royal College of Radiologists (Great Britain))
  • Adjuvant Radiotherapy Versus Wait-and-See Strategy for Pathologic T3 or Margin-Positive Prostate Cancer: A Meta-Analysis Shaikh, M. P.; Alite, F.; Wu, M. J.; Solanki, A. A.; Harkenrider, M. M., American Journal of Clinical Oncology
  • Bladder-Preserving Therapy Patterns of Care: A Survey of US Radiation Oncologists Solanki, A. A.; Martin, B.; Korpics, M.; Small, C.; Harkenrider, M. M.; Mitin, T., International journal of radiation oncology, biology, physics
  • Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy Korpics, M. C.; Block, A. M.; Martin, B.; Hentz, C.; Gaynor, E. R.; Henry, E.; Harkenrider, M. M.; Solanki, A. A., Cancer
  • Cranial Base Meningiomas Prabhu, V. C.; Melian, E.; Germanwala, A. V.; Solanki, A. A.; Borys, E.; Barton, K.; Anderson, D. E., World neurosurgery
  • Improving the Accessibility of Patient Care Through Integration of the Hospital and Radiation Oncology Electronic Health Records. Solanki, AA; Surucu, M; Bajaj, A; Kaczmarz, B; Martin, B; Price, J; Perino, C; McCoo, T; Payonk, G; Roeske, JC; Small, W, JCO clinical cancer informatics
  • Observer Evaluation of a Metal Artifact Reduction Algorithm Applied to Head and Neck Cone Beam Computed Tomographic Images Korpics, M.; Surucu, M.; Mescioglu, I.; Alite, F.; Block, A. M.; Choi, M.; Emami, B.; Harkenrider, M. M.; Solanki, A. A.; Roeske, J. C., International journal of radiation oncology, biology, physics
  • Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era. LeMieux, MH; Solanki, AA; Mahmood, U; Chmura, SJ; Koshy, M, Cancer medicine
  • Racial parities in outcomes after radiotherapy for head and neck cancer. Liu, GF; Ranck, MC; Solanki, AA; Cao, H; Kolokythas, A; Wenig, BL; Chen, L; Ard, S; Weichselbaum, RR; Halpern, H; Spiotto, MT, Cancer

Dr. Solanki's research focuses on advancing the treatment of patients with genitourinary cancers, brain and spine tumors, metastases from cancer, and optimizing quality and safety in radiation oncology.

These interests include the treatment of prostate cancer with high-dose-rate (HDR) prostate brachytherapy in the setting of newly diagnosed prostate cancer and those who have had recurrence after prior radiation therapy (radiorecurrence). Additionally, Dr. Solanki is also an leader in the treatment of bladder cancers, including the combination of immunotherapy with chemoradiation therapy for bladder preservation.

Dr. Solanki also conducts research identifying innovative methods to use modern information technologies to improve patient safety and quality in radiation oncology.